Millennium Management’s Ampio Pharmaceuticals AMPE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-2,008
| Closed | -$9K | – | 7138 |
|
|
2023
Q1 | $9K | Sell |
2,008
-1,136
| -36% | -$6.39K | ﹤0.01% | 6061 |
|
|
2022
Q4 | $14K | Sell |
3,144
-5,830
| -65% | -$37.6K | ﹤0.01% | 6138 |
|
|
2022
Q3 | $163K | Buy |
8,974
+2,189
| +32% | +$76.7K | ﹤0.01% | 5768 |
|
|
2022
Q2 | $342K | Buy |
6,785
+6,167
| +998% | +$459K | ﹤0.01% | 5258 |
|
|
2022
Q1 | $87K | Buy |
618
+395
| +177% | +$57.7K | ﹤0.01% | 6214 |
|
|
2021
Q4 | $38K | Buy |
+223
| New | +$83.1K | ﹤0.01% | 6533 |
|
|
2021
Q2 | – | Sell |
-6,368
| Closed | -$3.23M | – | 7355 |
|
|
2021
Q1 | $3.23M | Buy |
6,368
+5,458
| +600% | +$2.81M | ﹤0.01% | 3058 |
|
|
2020
Q4 | $434K | Buy |
910
+876
| +2,576% | +$287K | ﹤0.01% | 4307 |
|
|
2020
Q3 | $10K | Buy |
+34
| New | +$8.43K | ﹤0.01% | 4373 |
|
|
2020
Q1 | – | Sell |
-213
| Closed | -$37K | – | 4729 |
|
|
2019
Q4 | $37K | Sell |
213
-285
| -57% | -$36.8K | ﹤0.01% | 4114 |
|
|
2019
Q3 | $74K | Sell |
498
-5,827
| -92% | -$776K | ﹤0.01% | 4005 |
|
|
2019
Q2 | $736K | Buy |
+6,325
| New | +$1M | ﹤0.01% | 2991 |
|
|
2018
Q2 | – | Sell |
-2,608
| Closed | -$2.66M | – | 4312 |
|
|
2018
Q1 | $2.66M | Buy |
2,608
+1,990
| +322% | +$1.67M | ﹤0.01% | 2162 |
|
|
2017
Q4 | $755K | Sell |
618
-566
| -48% | -$266K | ﹤0.01% | 2875 |
|
|
2017
Q3 | $217K | Sell |
1,184
-356
| -23% | -$56.4K | ﹤0.01% | 3205 |
|
|
2017
Q2 | $241K | Buy |
+1,540
| New | +$311K | ﹤0.01% | 3123 |
|
|
2016
Q3 | – | Sell |
-58
| Closed | -$23K | – | 3721 |
|
|
2016
Q2 | $23K | Buy |
+58
| New | +$63.3K | ﹤0.01% | 3100 |
|
|
2016
Q1 | – | Sell |
-175
| Closed | -$183K | – | 3780 |
|
|
2015
Q4 | $183K | Sell |
175
-447
| -72% | -$442K | ﹤0.01% | 3124 |
|
|
2015
Q3 | $539K | Buy |
622
+39
| +7% | +$32.6K | ﹤0.01% | 2614 |
|
|
2015
Q2 | $415K | Buy |
+583
| New | +$621K | ﹤0.01% | 2727 |
|
|
2015
Q1 | – | Sell |
-69
| Closed | -$71K | – | 4256 |
|
|
2014
Q4 | $71K | Buy |
+69
| New | +$73.7K | ﹤0.01% | 3806 |
|
|
2014
Q3 | – | Sell |
-268
| Closed | -$670K | – | 4094 |
|
|
2014
Q2 | $670K | Buy |
268
+65
| +32% | +$133K | ﹤0.01% | 2417 |
|
|
2014
Q1 | $386K | Buy |
+203
| New | +$480K | ﹤0.01% | 2784 |
|
Other funds holding AMPE
Millennium Management's AMPE Position: Q2 2023 in Review
Millennium Management sold out of Ampio Pharmaceuticals (AMPE) in Q2 2023, closing a stake of 2,008 shares — an estimated $9K sold.
Millennium Management first reported a position in AMPE in Q1 2014 and held it in 23 quarters. The position peaked at $3.23M in Q1 2021. 34 funds tracked by Wall St. Rank hold AMPE as of Q2 2023.
- Millennium Management reported no remaining Ampio Pharmaceuticals position as of Q2 2023 after selling out during the quarter.
- Millennium Management sold 2,008 Ampio Pharmaceuticals shares in Q2 2023, an estimated $9K.
- Millennium Management first reported a position in Ampio Pharmaceuticals in Q1 2014 and held it in 23 quarters.
- Millennium Management's Ampio Pharmaceuticals position peaked at $3.23M in Q1 2021.
- 34 funds tracked by Wall St. Rank held Ampio Pharmaceuticals as of Q2 2023.
Based on Millennium Management's 13F filing for Q2 2023, filed 14 Aug 2023.